GLP-1 Addiction Reduction Evidence in Rodents and Primates Randomized controlled trials in mice, rats, and monkeys have shown strong anti-addiction effects from GLP-1RAs
Chamani M, Asgari S, Najmeddin A, Pourjavadi A, Amin M, Gholami M, Dorkoosh FA
Breakthrough Prize recognizes Daniel Drucker for work leading to diabetes, anti-obesity drugs Daniel Drucker , the Canadian scientist renowned for discoveries that sparked the advent of Ozempic and other GLP-1 medicines for diabetes and obesity, has added yet another accolade to his growing collection: the 2025 Breakthrough Prize in Life Sciences
This reinforces its alignment with holistic health goals rather than short-term aesthetics
There is also evidence for mechanisms involving a reduction of neuroinflammation, an increase in synaptic functioning, as well as the restoration of brain pathways of insulin signaling that may lead to improved memory formation and therefore a positive effect in Alzheimers disease and Parkinsons disease 34